Source:http://linkedlifedata.com/resource/pubmed/id/11841613
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1 Suppl
|
pubmed:dateCreated |
2002-3-7
|
pubmed:abstractText |
Congenital absence of alpha-galactosidase in Fabry disease leads eventually to renal failure. Fabry disease is an attractive candidate for gene therapy, but uptake mechanisms of the enzyme must be understood for it to be used in treating patients with Fabry disease.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1523-1755
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
61
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
S52-5
|
pubmed:meshHeading | |
pubmed:year |
2002
|
pubmed:articleTitle |
Polarity of alpha-galactosidase A uptake by renal tubule cells.
|
pubmed:affiliation |
Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|